AVITA Medical (RCEL) Return on Invested Capital (2025)

AVITA Medical (RCEL) posted Return on Invested Capital of 0.01% for Q4 2025, up 80.38% on a QoQ basis from 0.06% in Q3 2025.

AVITA Medical (RCEL) Return on Invested Capital (2025) Analysis & Trends

AVITA Medical's Return on Invested Capital history runs 1 years deep, the most recent figure standing at 0.01% for Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	184.21 Bn	176.92 Bn	6.27 Bn	0.01%
2	Stryker	128.90 Bn	126.02 Bn	3.81 Bn	0.01%
3	Medtronic	109.00 Bn	99.78 Bn	6.41 Bn	0.01%
4	Boston Scientific	68.62 Bn	67.16 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	47.39 Bn	43.72 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.44 Bn	26.16 Bn	1.98 Bn	0.00%
7	Dexcom	28.39 Bn	27.27 Bn	750.30 Mn	-
8	Smith & Nephew	27.03 Bn	26.46 Bn	-	-
9	Koninklijke Philips	25.55 Bn	22.43 Bn	2.07 Bn	0.00%
10	AVITA Medical	134.29 Mn	117.95 Mn	14.31 Mn	-0.01%

Download Data